Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor.
about
Intimate cross-talk between cancer cells and the tumor microenvironment of B-cell lymphomas: The key role of exosomes.The Role of Checkpoint Inhibition in Non-Small Cell Lung Cancer.Significant benefit of Nivolumab treating PD-L1 positive metastatic pulmonary carcinosarcoma: a case report and literature review.New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.Ipilimumab for the treatment of metastatic prostate cancer.Immune checkpoint inhibitors in advanced non-small cell lung cancer.Nivolumab Induces Sustained Liver Injury in a Patient with Malignant Melanoma: A Case Report.Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients.The Use of the Humanized Mouse Model in Gene Therapy and Immunotherapy for HIV and Cancer.Optimized Expression and Characterization of a Novel Fully Human Bispecific Single-Chain Diabody Targeting Vascular Endothelial Growth Factor165 and Programmed Death-1 in and Evaluation of Antitumor Activity In Vivo
P2860
Q39376074-60F67060-46FA-4629-A81B-7936F4D3F2E5Q47095389-F2EA8B95-BA0E-44C6-BDC0-5151B5A5E739Q47139741-6FC159AA-75D2-4E7D-99C2-7EE0B80256B9Q47221234-2265DAFD-4958-4E13-A6C4-F4AC7EF9EB20Q47225399-3C688EF6-A45C-4ADA-8028-07203A486C64Q47563451-32E999C4-3D83-4E2F-87CE-BDFCA5A6EE4BQ50055764-CBA9D775-B4AA-4DDA-A465-81C15A6B5579Q52641866-D54532D4-6392-4062-B989-DE466F3BC9AEQ55078034-0EA76ADA-B1E4-45E2-9539-65C31619DB0DQ59138239-8F38BC0A-5027-44E1-A4ED-6640FA37D9EA
P2860
Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor.
@en
Nivolumab as Programmed Death-1
@nl
type
label
Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor.
@en
Nivolumab as Programmed Death-1
@nl
prefLabel
Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor.
@en
Nivolumab as Programmed Death-1
@nl
P2093
P2860
P356
P1433
P1476
Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor.
@en
P2093
Baoan Chen
Haijun Zhang
Liting Guo
P2860
P304
P356
10.7150/JCA.17144
P577
2017-02-10T00:00:00Z